OpenAlex
PricingAboutJobs
Log inGet started
Work

DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes

HTML

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Clinical Endocrinology & Metabolism
DOI: 10.1210/jc.2010-2081
Authors: Thomas Blevins, John Pullman, Jaret Malloy, Ping Yan, Kristin Taylor, Christine Schulteis, Michael Trautmann, Lisa Porter
Institutions: Texas Diabetes & Endocrinology, Eli Lilly (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, weekly dosing, twice-daily dosing, GLP-1 receptor agonists, type 2 diabetes, glycemic control, HbA1c, fasting blood glucose, body weight, nausea, injection site reactions, hypoglycemia, drug-naive patients
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2043900831
FWCI: 38.03
Cites: 37
Cited by: 465
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security